sunitinib sandoz 25 mg hartkapsel
sandoz - sunitinib - hartkapsel - 25 mg - sunitinib 25 mg - sunitinib
sunitinib sandoz 50 mg hartkapsel
sandoz - sunitinib - hartkapsel - 50 mg - sunitinib 50 mg - sunitinib
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib eg 12,5 mg hartkapsel
eurogenerics afgekort "e.g." - sunitinib - hartkapsel - 12,5 mg - sunitinib 12.5 mg - sunitinib
sunitinib eg 25 mg hartkapsel
eurogenerics afgekort "e.g." - sunitinib - hartkapsel - 25 mg - sunitinib 25 mg - sunitinib
sunitinib eg 37,5 mg hartkapsel
eurogenerics afgekort "e.g." - sunitinib - hartkapsel - 37,5 mg - sunitinib 37.5 mg - sunitinib
sunitinib eg 50 mg hartkapsel
eurogenerics afgekort "e.g." - sunitinib - hartkapsel - 50 mg - sunitinib 50 mg - sunitinib
sunitinib aqvida 25 mg hartkapseln
aqvida gmbh (8135745) - sunitinib-l-malat - hartkapsel - sunitinib-l-malat (31912) 32,8 milligramm
sunitinib aqvida 12,5 mg hartkapseln
aqvida gmbh (8135745) - sunitinib-l-malat - hartkapsel - sunitinib-l-malat (31912) 16,4 milligramm
sunitinib aqvida 37,5 mg hartkapseln
aqvida gmbh (8135745) - sunitinib-l-malat - hartkapsel - sunitinib-l-malat (31912) 49,1 milligramm